NB-UVB: Clinical Trials

4 trials of NB-UVB, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated, 1 unknown. 4 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 2, Terminated 1, Unknown 1
Phase 21Completed 1

Follow NB-UVB: new trials by email Literature Review of NB-UVB trials Research Report on NB-UVB

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Plexin B2 Gene Expression and Polymorphisms in Psoriasis
Narrow band Ultraviolet B phototherapy group, Acitretin group, Acitretin plus Narrow band Ultraviolet B phototherapy group - Psoriasis Vulgaris
Phase 1CompletedSouth Valley University2002021-09-012023-09-21
Immunogenetic Profiling of Goeckerman Therapy in the Treatment of Psoriasis Vulgaris
Goeckerman Therapy, Crude Coal Tar Only, Phototherapy Only - Psoriasis Vulgaris, Psoriasis
Phase 1TerminatedUniversity of California, San Francisco42018-08-012025-08-03
The Effect of Fractional Co2 Laser Either With Tacrolimus, Calcipotriol or NB-UVB in Stable Generalized Vitiligo
Tacrolimus ointment, calcipotriol ointment, NB-UVB - Vitiligo Vulgaris
Phase 1UnknownAssiut University302017-08-012017-08-01
To Study the Use of Humanized CD25 in Preventing the Relapse of Psoriasis Vulgaris
Daclizumab, NB-UVB - Psoriasis
Phase 1 / Phase 2CompletedRockefeller University61997-10-012009-03-25

Conditions studied

Psoriasis (2)  ·  Vitiligo (1)

Sponsors

Assiut University (1)  ·  Rockefeller University (1)  ·  South Valley University (1)  ·  University of California, San Francisco (1)

Countries

United States (2)  ·  Egypt (1)

Top investigators

Eisa Hegazy, Prof. (1)  ·  James Krueger, MD, PHD (1)  ·  Tina Bhutani, MD (1)

Results publications

PMID 19787413, PMID 21451378, PMID 23919018, PMID 25596811